Skip to main content
    T

    Translational Development Acquisition Corp. Ordinary Shares (TDAC)

    Official site

    FINANCIAL SERVICES • SHELL COMPANIES • NASDAQ

    $10.82
    +0.01 (+0.09%)

    Market Cap: $208.73M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    PeriodReportedEst.SurpriseB/MYoY
    Jun 26
    Reported Aug 14
    		$0.04N/AN/ABeat-37.1%
    Mar 26
    Reported May 15
    		$0.06N/AN/ABeat-13.1%
    Dec 25
    Reported Mar 16
    		$0.07N/AN/ABeat-
    Sep 25
    Reported Nov 14
    		$0.08N/AN/ABeat-
    Jun 25
    Reported Aug 14
    		$0.07N/AN/ABeat-
    Mar 25
    Reported May 15
    		$0.07N/AN/ABeat-
    Dec 24
    Reported Mar 31
    		$0.00$0.00N/ABeat-

    Key Metrics

    Valuation
    P/E Ratio42.00EV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE0.00%ROIC16.25%
    Financial Health
    Debt/Equity-0.14xInterest CoverageN/A
    Current Ratio0.06xQuick Ratio0.06x
    Trading Statistics
    BetaN/AAvg Volume6.25K
    52-Week High$10.9552-Week Low$10.39

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$10.82
    SMA 20$10.84
    SMA 50$10.85
    SMA 200$10.68
    EMA 10$10.83
    EMA 20$10.83
    EMA 50$10.83
    EMA 200$10.69

    MACD

    Line: -0.01Signal: -0.01Hist: -0.00

    ADX

    ADX: 41.3+DI: 25.6-DI: 13.6

    Aroon & PSAR

    Aroon Up12.0
    Aroon Down96.0
    PSAR$10.90

    Bollinger Bands

    Upper Band$10.89
    Lower Band$10.79
    %B Position85%(Upper)
    Band Width0.29

    RSI (14-Day)

    Neutral
    45.7

    Momentum Oscillators

    Stoch %K20.0
    Stoch %D23.9
    Williams %R-80.0
    ROC (10d)-0.2%
    Momentum-0.03
    CCI (20d)-64.3
    MFI (14d)21.6

    Volatility Measures

    ATR (14d)$0.04(0.4%)
    StdDev (20d)0.02
    Hist Vol2.7%(Low)

    Volume Flow

    VWAP$10.82
    OBV5.4M
    AD Line-727.2K
    CMF (20d)-0.444

    Volume Metrics

    Avg Vol (20d)6.2K
    Vol Ratio0.2x(Low)
    VWMA (20d)$10.84

    Pivot Points

    R3$10.86
    R2$10.84
    R1$10.83
    Pivot Point$10.81
    S1$10.80
    S2$10.78
    S3$10.77

    Advanced Oscillators

    TSI-8.09
    Ultimate Osc26.6
    KST-3.08

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$0$0$-553,290$0$0$0$0$0$0$0$0$0
    Cost of Revenue$0$0$-530,069$0$0$0N/A$0$0$0N/AN/A
    Gross Profit$0$0$-23,221$0$0$0N/A$0$0$0N/AN/A
    Operating Expenses$661,050$281,161$162,345$213,658$221,127$347,408$133,390$61,283$1,685$0$483,846$500
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$661,050$281,161$162,345$213,658$221,127$347,408$133,390$61,283$1,685$0$483,846$500
    Operating Income$-661,050$-281,161$-162,345$-213,658$-221,127$-347,408$-133,390$-61,283$-1,685$0$-483,846$-500
    Interest Income$1.64M$1.61M$1.76M$1.87M$1.84M$1.83M$125,346$0$0$0$0$0
    Interest Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Income Before Tax$946,982$1.33M$1.60M$1.66M$1.62M$1.48M$-8,044$-61,283$-1,685$0$-483,846$-500
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$946,982$1.33M$1.60M$1.66M$1.62M$1.48M$-8,044$-61,283$-1,685$0$-483,846$-500
    EBITDA$-697,188$-281,161$-162,345$-213,658$-221,127$-347,408$-133,390$-61,283$-1,685$0$-483,846$-500
    EBIT$-697,188$-281,161$-162,345$-213,658$-221,127$-347,408$-133,390$-61,283$-1,685$0$-483,846$-500
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about TDAC

    News

    Form 4 Translational Development Acquisition Corp For: 8 October By Investing.com

    This article reports on a Form 4 filing for Translational Development Acquisition Corp (TDAC) on October 8. It includes the date of publication, the company's stock symbol...

    Investing.com Nigeria•10/8/26•Neutral

    Form 4 Translational Development Acquisition Corp For: 8 October By Investing.com

    This article reports on the filing of Form 4 by Translational Development Acquisition Corp for October 8. It provides financial market data including indices, commodities...

    Investing.com Canada•10/8/26•Neutral

    Translational Development Investor Alert: Kahn Swick & Foti, LLC Investigates Translational Development Acquisition Corp. - TDAC

    Kahn Swick & Foti, LLC (KSF) is investigating the proposed merger between Translational Development Acquisition Corp. (TDAC) and Prologium Holding Inc. The firm aims to determine if the merger is fair to Translational...

    Business Wire•8/20/26•Somewhat-Bearish

    Meteora Capital (TDAC) discloses 919,000-share beneficial stake in SPAC

    Meteora Capital, LLC and its managing member Vik Mittal, have reported a beneficial ownership of 919,000 shares of Translational Development Acquisition Corp. (TDAC) Class A Common Stock...

    Stock Titan•8/14/26•Neutral

    Translational Development Acquisition (TDAC): Linden Advisors reports 6.7% ownership stake

    Linden Advisors and related entities, including Siu Min (Joe) Wong, have reported a significant ownership stake in Translational Development Acquisition Corp. (TDAC). They beneficially own 1,150,000 Class A Ordinary...

    Stock Titan•8/14/26•Neutral

    TDAC Valuation and Fair Value

    P/E
    42.0x
    P/B
    -30.3x
    See GNG's fair value

    TDAC Profitability: Margins, ROIC and FCF

    Operating margin
    0.0%
    Net margin
    0.0%
    ROIC
    16.2%
    ROE
    0.0%

    TDAC Competitors

    CompanyTicker
    Onity Group Inc.ONIT
    Georgia Power CoGPJA
    NewHold Investment Corp III WarrantsNHICW
    Eagle Point Income Company IncEIC
    Gesher Acquisition Corp. IIGSHR
    First Capital IncFCAP
    Ohio Valley Banc CorpOVBC
    Chicago Atlantic BDC, Inc.LIEN

    Sector: Financial Services

    TDAC Bull Case vs Bear Case

    Bull case

    • TDAC earns a 16.2% return on invested capital.

    Bear case

    • TDAC trades at 42.0x trailing earnings.

    Frequently Asked Questions About TDAC

    Does TDAC pay dividends?

    Translational Development Acquisition Corp. Ordinary Shares (TDAC) does not currently pay a regular dividend.

    What is TDAC's P/E ratio?

    Translational Development Acquisition Corp. Ordinary Shares has a price-to-earnings (P/E) ratio of 42.00.

    What is TDAC's market cap?

    Translational Development Acquisition Corp. Ordinary Shares (TDAC) has a market capitalization of $208.73M with a current stock price of $10.82.

    Related stocks

    Sector: Financial Services

    All stocks starting with T

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In